Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 305908, 17 pages
http://dx.doi.org/10.1155/2009/305908
Research Article

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

1Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
2Department of Radiology, “AHEPA” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
3Siemens Healthcare Diagnostics, Cologne, Germany
4Department of Otorhinolaryngology, “AHEPA” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
5Department of Pathology, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
6Department of Molecular Biology and Genetics, “Metropolitan” Hospital, Piraeus, Greece
7Laboratory of Molecular Biology, Department of Obstetrics and Gynecology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece
8Third Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, Athens, Greece
9Department of Radiation Oncology, “Agios Savvas” Cancer Hospital, Athens, Greece
10Department of Radiation Oncology, “Papageorgiou” Hospital, Thessaloniki, Greece
11Hellenic Cooperative Oncology Group (HeCOG), Data Office, Athens, Greece
12Second Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

Received 27 February 2009; Revised 28 July 2009; Accepted 10 September 2009

Academic Editor: Amanda Psyrri

Copyright © 2009 George Fountzilas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • Samuel Murray, Mattheos Bobos, Nikolaos Angouridakis, Angelos Nikolaou, Helena Linardou, Evangelia Razis, and George Fountzilas, “Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study,” Journal of Oncology, vol. 2010, pp. 1–10, 2010. View at Publisher · View at Google Scholar
  • Tai-Jan Chiu, Chang-Han Chen, Chih-Yen Chien, Shau-Hsuan Li, Hsin-Ting Tsai, and Yi-Ju Chen, “High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area,” Journal of Translational Medicine, vol. 9, 2011. View at Publisher · View at Google Scholar
  • Gilberto De Castro, Fatima Solange Pasini, Sheila Aparecida Coelho Siqueira, Alberto Rossetti Ferraz, Rosangela Correa Villar, Igor Moyses Longo Snitcovsky, and Miriam Hatsue Honda Federico, “ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic marke rs in head and neck squamous cell carcinoma patients treated with surgery a nd adjuvant cisplatin-based chemoradiation,” Oncology Reports, vol. 25, no. 3, pp. 693–699, 2011. View at Publisher · View at Google Scholar
  • Vassiliki Kotoula, Sofia Lambaki, Despina Televantou, Anna Kalogera-Fountzila, Angelos Nikolaou, Konstantinos Markou, Despina Misailidou, Konstantinos N. Syrigos, and George Fountzilas, “STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN,” Translational Oncology, vol. 4, no. 1, pp. 47–58, 2011. View at Publisher · View at Google Scholar
  • Alec Vaezi, Chelsea H Feldman, and Laura J Niedernhofer, “ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer.,” Pharmacogenomics and personalized medicine, vol. 4, pp. 47–63, 2011. View at Publisher · View at Google Scholar
  • Siv K. Bohn, Kjell M. Russnes, Amrit K. Sakhi, Magne Thoresen, Marit Holden, Jan O. Moskaug, Mari C. Myhrstad, Ole K. Olstad, Sigbjorn Smeland, and Rune Blomhoff, “Stress associated gene expression in blood cells is related to outcome in r adiotherapy treated head and neck cancer patients,” Bmc Cancer, vol. 12, 2012. View at Publisher · View at Google Scholar
  • Samuel Murray, Vasilios Karavasilis, Mattheos Bobos, Evangelia Razis, Savvas Papadopoulos, Christos Christodoulou, Paris Kosmidis, and George Fountzilas, “Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer,” Journal Of Experimental & Clinical Cancer Research, vol. 31, 2012. View at Publisher · View at Google Scholar
  • Vesna Bišof, Antonija Jakovcevic, Sven Seiwerth, Zoran Rakušic, and Slavko Gašparov, “Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy,” Journal of Cancer Research and Clinical Oncology, vol. 139, no. 2, pp. 187–194, 2012. View at Publisher · View at Google Scholar
  • József Dudás, Heinz Zwierzina, and Georg Mathias Sprinzl, “New drugs for head and neck cancer,” Memo - Magazine of European Medical Oncology, vol. 5, no. 3, pp. 236–241, 2012. View at Publisher · View at Google Scholar
  • Roger B. Cohen, “Current Challenges and Clinical Investigations of Epidermal Growth Factor Receptor (EGFR)- and ErbB Family-targeted Agents in the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC),” Cancer Treatment Reviews, 2013. View at Publisher · View at Google Scholar
  • Mihir R. Patel, Andrew F. Olshan, Carol G. Shores, D. Neil Hayes, Ni Zhao, Mei-Kim Ang, Michael E. Stadler, Karen Fritchie, Mark C. Weissler, Adam M. Zanation, Stephen L. Harris, and William K. Funkhouser, “ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma,” Otolaryngology - Head and Neck Surgery (United States), vol. 149, no. 4, pp. 587–595, 2013. View at Publisher · View at Google Scholar
  • Amanda Psyrri, and Urania Dafni, “Combining Cetuximab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: Is More Better?,” Journal of Clinical Oncology, vol. 32, no. 27, pp. 2929–+, 2014. View at Publisher · View at Google Scholar
  • Vesna Bišof, Matea Zajc Petranović, Zoran Rakušić, Kristina Ruža Samardžić, and Antonio Juretić, “The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis,” European Archives of Oto-Rhino-Laryngology, vol. 273, no. 9, pp. 2305–2317, 2015. View at Publisher · View at Google Scholar
  • Katharine A.R. Price, and Ezra E.W. Cohen, “Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN),” Oral Oncology, 2015. View at Publisher · View at Google Scholar
  • George Fountzilas, Amanda Psyrri, Eleni Giannoulatou, Ioannis Tikas, Kyriaki Manousou, Dimitra Rontogianni, Elisabeta Ciuleanu, Tudor Ciuleanu, Liliana Resiga, Thomas Zaramboukas, Kyriaki Papadopoulou, Mattheos Bobos, Sofia Chrisafi, Eleftheria Tsolaki, Konstantinos Markou, Evangelos Giotakis, Angelos Koutras, Elsa Psoma, Anna Kalogera-Fountzila, Maria Skondra, Christina Bamia, Dimitrios Pectasides, and Vassiliki Kotoula, “ Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe ,” International Journal of Cancer, 2017. View at Publisher · View at Google Scholar
  • P. Szturz, E. Raymond, C. Abitbol, S. Albert, A. de Gramont, and S. Faivre, “Understanding c-MET signalling in squamous cell carcinoma of the head & neck,” Critical Reviews in Oncology/Hematology, vol. 111, pp. 39–51, 2017. View at Publisher · View at Google Scholar
  • Ibrahima Téguété, Amadou Dolo, Kotou Sangare, Abdoulaye Sissoko, Mali Rochas, Sarah Beseme, Karamoko Tounkara, Shahla Yekta, Anne S. De Groot, and Ousmane A. Koita, “Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali,” Plos One, vol. 12, no. 2, pp. e0172661, 2017. View at Publisher · View at Google Scholar
  • Gabriele Simontacchi, Giulio Francolini, Saverio Caini, Lorenzo Livi, Mauro Loi, Emanuela Olmetto, Camilla Delli Paoli, Francesca Terziani, Daniela Greto, Monica Mangoni, Silvia Scoccianti, Pierluigi Bonomo, Icro Meattini, and Isacco Desideri, “Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review,” Critical Reviews in Oncology/Hematology, vol. 120, pp. 98–110, 2017. View at Publisher · View at Google Scholar
  • Petr Szturz, Marie Budíková, Jan B. Vermorken, Ivana Horová, Břetislav Gál, Eric Raymond, Armand de Gramont, and Sandrine Faivre, “Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data,” Oral Oncology, vol. 74, pp. 68–76, 2017. View at Publisher · View at Google Scholar
  • Lanlan Yang, Ann-Marie Ritchie, and David W. Melton, “Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1,” Oncotarget, vol. 8, no. 33, pp. 55246–55264, 2017. View at Publisher · View at Google Scholar